improving clinical trials

The National Institutes of Health wants to hear from parents and professionals about their experiences with the recent ataluren trials in Duchenne/Becker muscular dystrophies

posted on December 21, 2010 - 3:03pm
If your child participated in a phase 2 clinical trial of ataluren (PTC124) for Duchenne muscular dystrophy (DMD) or Becker muscular dystrophy (BMD) conducted by PTC Therapeutics, you're invited to take part in a National Institutes of Health (NIH) study about the experience.

New content is being added every day. Please check back again.